Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 3 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

1
Player Avatar Radiohead101 (50.79) Submitted: 1/25/2011 4:59:44 PM : Outperform Start Price: $15.75 QCOR Score: +161.48

Emerging healthcare

Report this Post Reply

Featured Broker Partners


Advertisement